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Background: N-myc downstream-regulated gene 2 (NDRG2), 
a member of a newly described family of differentiation-re-
lated genes, has been characterized as a regulator of den-
dritic cells. However, the role of NDRG2 on the expression 
and activation of transcription factors in blood cells remains 
poorly understood. In this study, we investigated the effects 
of NDRG2 overexpression on GATA-1 expression in PMA- 
stimulated U937 cells. Methods: We generated NDRG2- 
overexpressing U937 cell line (U937-NDRG2) and treated 
the cells with PMA to investigate the role of NDRG2 on 
GATA-1 expression. Results: NDRG2 overexpression in U937 
cells significantly induced GATA-1 expression in response to 
PMA stimulation. Interestingly, JAK2/STAT and BMP-4/ 
Smad pathways associated with the induction of GATA-1 
were activated in PMA-stimulated U937-NDRG2 cells. We 
found that the inhibition of JAK2 activation, but not of BMP- 
4/Smad signaling, can elicit a decrease of PMA-induced 
GATA-1 expression in U937-NDRG2 cells. Conclusion: The 
results reveal that NDRG2 promotes the expression of 
GATA-1 through activation of the JAK2/STAT pathway, but 
not through the regulation of the BMP-4/Smad pathway in 
U937 cells. Our findings further suggest that NDRG2 may 
play a role as a regulator of erythrocyte and megakaryocyte 
differentiation during hematopoiesis.
[Immune Network 2011;11(6):348-357]
INTRODUCTION
Hematopoiesis is controlled by a number of cell type-specific 
transcription factors that induce differentiation of cells to fulfill 
particular functions (1). These factors give rise to a specific 
lineage commitment via a coordinated regulation of expres-
sion and activation. However, little is known about how tran-
scription factors regulate hematopoiesis. To this end, it is im-
portant to gain an understanding of how transcription factors 
are  modulated  during  the  differentiation  of  hematopoietic 
cells.
    Globin  transcription  factor  1  (GATA  binding  protein  1, 
GATA-1) is a transcription factor known to be involved in the 
development of various hematopoietic lineages (2). GATA-1 
is  a  C4  zinc  finger  transcription  factor  that  recognizes 
WGATAR DNA motifs and is essential for erythrocyte, mega-
karyocyte, mast cell, and eosinophil differentiation. GATA-1 
has a reciprocal interaction with PU.1, another transcription 
factor that promotes macrophage and dendritic cell develop-
ment (3). It has been reported that there are various genes 
associated with the modulation of GATA-1 expression. A gain 
of  function  JAK2 ( JAK2
V617F)  mutation  leads  to  enhanced 
GATA-1  expression,  whereas  morpholino  knock-down  of 
jak2a  or  a  specific  JAK2  inhibitor  (TG101209)  significantly 
suppresses  GATA-1  expression  in  zebrafish  embryos  (4,5). 
Rab7b-induced IL-6 production and STAT3 activation promote 
GATA-1 activity in K562 cells (6). GATA-1 expression is also 
increased by treatment with recombinant BMP-4, but is redu-
ced by Smad5 knockdown in the embryoid body (EB) (7,8). 
Moreover,  dorsomorphin,  a  selective  inhibitor  of  BMP-in-
duced Smad activation, decreases expression of GATA-1 dur-
ing  embryonic  stem  (ES)  cell  differentiation  (9,10).  Ectopic 
expression of erythroid differentiation-associated gene (EDAG) 
induces GATA-1 expression in 32D cells (11), whereas HSP27 
promotes  ubiquitination  of  GATA-1  in  K562  cells  (12).NDRG2 Induces GATA-1 in PMA-stimulated U937 Cells
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    N-myc downstream-regulated gene 2 (NDRG2) belongs to 
the NDRG family, a new family of differentiation-related genes 
composed of four members which share 57∼65% amino acid 
identity  (13).  NDRG  proteins  have  common  structural  fea-
tures, including an NDR-domain and an α/β hydrolase fold, 
which show high homology among NDRG members (13). Of 
the NDRG family members, NDRG2 is highly expressed in the 
adult brain, salivary glands, and skeletal muscle (13). It has 
been characterized as a regulator of dendritic cell differentia-
tion from monocytes, CD34
＋ progenitor cells, and myelomo-
nocytic  leukemic  cell  line  (14,15).  NDRG2  has  also  been 
shown to regulate cell growth, apoptosis, and neurodegene-
ration (16-19). Recently, it has been proposed to be a novel 
intrinsic factor for the modulation of IL-10 production in mye-
loid cells (20). However, the role of NDRG2 in the expression 
and activation of transcription factors in blood cells has re-
mained  poorly  understood.
    Interestingly, NDRG2 overexpression induces a significant 
decrease  of  PU.1  expression  in  U937  cells.  We  previously 
showed  that  NDRG2  overexpression  activates  the  STAT3 
pathway  in  PMA-treated  U937  cells  (21)  and  also  induces 
BMP-4  production  in  MDA-MB-231  cells  (17).  Given  that 
STAT3 and BMP-4 are involved in GATA-1 expression, and 
that NDRG2 inhibits PU.1 expression, we hypothesized that 
NDRG2  increases  GATA-1  expression  through  regulation  of 
either the JAK2/STAT or BMP-4/Smad pathway. To test this 
hypothesis,  we  investigated  whether  NDRG2  promotes  ex-
pression  of  GATA-1  in  PMA-stimulated  U937  cells.  GATA-1 
expression was substantially increased in NDRG2-overexpres-
sing U937 cells in response to PMA. In addition, NDRG2 ex-
pression  induced  activation  of  the  JAK2/STAT  and  BMP-4/ 
Smad  pathway  in  PMA-stimulated  U937  cells.  Inhibition  of 
JAK2  decreased  PMA-induced  GATA-1  expression  in  U937- 
NDRG2 cells. However, inhibition of the BMP-4/Smad path-
way  did  not  suppress  PMA-induced  GATA-1  expression  in 
U937-NDRG2 cells. Taken together, these data indicate that 
NDRG2 expression promotes the GATA-1 expression through 
r e g u l a t i o n  o f  t h e  J A K 2 / S T A T  p a t h w a y  a n d  n o t  t h r o u g h  t h e  
BMP4/Smad  pathway  in  U937  cells.  Additionally,  we  spec-
ulate that NDRG2 can serve as a regulator of erythrocyte and 
megakaryocyte  differentiation  during  hematopoiesis.
MATERIALS AND METHODS
Cell lines and reagents
U937  cells  were  cultured  in  RPMI  1640  (Gibco/Invitrogen, 
Carlsbad,  CA)  supplemented  with  10%  heat-inactivated  FBS 
(Gibco). Phorbol 12-myristate 13-acetate (PMA), AG490, and 
dorsomorphin  (6-[4-(2-piperidin-1-yl-ethoxy)  phenyl]-3-pyr-
idin-4-yl-pyrazolo  [1,5-a]  pyrimidine)  were  purchased  from 
Sigma-Aldrich  (St.  Louis,  MO).  Recombinant  human  noggin 
was  obtained  from  Peprotech,  Inc.  (Rocky  Hill,  NJ).
Construction and transfection of U937 cells
Cells  expressing  NDRG2  were  previously  generated  in  our 
laboratory (20). Among the established clones, clone #61 was 
used  as  a  stable  NDRG2-expressing  U937  cell  line.
RT-PCR
T o t a l  R N A  f r o m  h a r v e s t e d  c e l l s  w a s  i s o l a t e d  u s i n g  t h e  T R I  
reagent (Molecular Research Center, Cincinnati, OH). cDNA 
was synthesized from 1μg of total RNA and amplified by PCR 
for 35∼40 cycles in a 20μl reaction mixture containing 1μl 
cDNA, 10 pmol of each primer, 10 mM dNTP, and 0.5 U Taq 
DNA polymerase (Bioneer, Daejeon, Republic of Korea). β- 
actin was amplified for 22 cycles and used as a loading con-
trol. PCR products (10μl) were electrophoresed on a 1% aga-
rose gel and visualized by ethidium bromide staining. The pri-
mer sequences used for RT-PCR are summarized in Table I.
Western blot analysis
The cells were lysed in a protein extraction solution (iNtRON 
Biotechnology, Seongnam, Korea). The proteins were sepa-
rated  on  an  SDS-polyacrylamide  gel  and  transferred  onto  a 
PVDF  membrane  (Amersham  Biosciences,  Burkes,  UK), 
which was then blocked with Tris-buffered saline and 0.05% 
Tween-20 (TBST) containing 5% skim milk. The membranes 
were  incubated  with  specific  antibodies  and  washed  with 
TBST. The antibodies for phospho-STAT1, phospho- STAT3, 
phospho-STAT5, phospho-Smad1/5/8, and Smad5 were pur-
chased  from  Cell  Signaling  Technology  Inc.  (Beverly,  MA). 
Antibodies against GATA-1, SOCS1, SOCS2, SOCS3, NDRG2, 
Lamin A/C, actin, and α-actinin were purchased from Santa 
Cruz Biotechnology (Santa Cruz, CA). The phospho-JAK2 an-
tibody was purchased from Millipore (Billerica, MA), and the 
antibody  against  BMP-4  was  purchased  from  R&D  Systems 
(Minneapolis, MN). After incubating the membrane with di-
luted secondary antibody coupled to horseradish peroxidase, 
the antigen-antibody complexes were detected by enhanced 
chemiluminescence and exposed using LAS 3000 imaging sys-
tem  (FUJIFILM  Corporation,  Tokyo,  Japan).NDRG2 Induces GATA-1 in PMA-stimulated U937 Cells
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Table I. PCR primers
Gene Sense primer Antisense primer
   PU.1 5’-GCA GGC CCT TCG ATA AAA TC-3’ 5’-GCG TTT GGC GTT GGT ATA GA-3’
   CSF-1R 5’-AGT GCA GTG GCC ACA CTG AT-3’ 5’-AGC TCC GAG GGT CTT ACC AA-3’
   GATA-1 (35)
§ 5’-TTT CCA GTA CCT TCT TTT CTC CC-3’ 5’-ACA GTG GAG TGG CTG TTG CTC-3’
   SOCS1 (21) 5’-AGA CCC CTT CTC ACC TCT TG-3’ 5’-CTG CAC AGC AGA AAA TAA AGC-3’
   SOCS2 (21) 5’-GGA TGG TAC TGG GGA AGT ATG ACT-3’ 5’-AGT GGA TCA GAT GAA CCA CAC TCT-3’
   SOCS3 (21) 5’-CAC ATG GCA CAA GCA CAA GA-3’ 5’-AAG TGT CCC CTG TTT GGA GG-3’
   SOCS4 (21) 5’-AGA GAA GGT CCT ATG ACT GG-3’ 5’-GGG CAT CGA TGC CAT CAT AA-3’
   SOCS5 (21) 5’-CAG TTC TGC AAT TCC ACA AG-3’ 5’-GAC TGG TTC TCG TTC CAA CC-3’
   BMPRIA 5’-GCA TAA CTA ATG GAC ATT CCT-3’ 5’-TAG AGT TTC TCC TCC GAT GG-3’ 
   BMPRIB 5’-GCA GCA CAG ACG GAT ATT GT-3’ 5’-TTT CAT GCC TCA TCA ACA CT-3’
   BMPRII 5’-ACG GGA GAG AAG ACG AGC CT-3’ 5’-CTA GAT CAA GAG AGG GTT CG-3’
   ActRI 5’-GCA TTC CCA GAG CAC CAA-3’ 5’-CTG TGA GTC TTG CGG ATG GA-3’
   ActRII 5’-ATG GCT AGA GGA TTG GCA TAT T-3’ 5’-TCT TCA ATG GTT TCA CAG AGC A-3’
   ActRIIB 5’-ACA GGT AGG CAC GAG ACG GT-3’ 5’-GTA GTG CCG TTG ACC GAC CT-3’
   PC1/3 5’-TCC ACA CTG GCC ACC TCT TA-3’ 5’-GCC TGC TCC ATT CTT TTT CC-3’
   PC2 5’-CAA GCA GCA GCT GGA GAG AG-3’ 5’-CAG GTC CGG GTG GAG ATA GT-3’
   PC4 5’-CTG GGC CTA GAG AAC AAG GG-3’ 5’-CAG CCT TGT GTG GTT GAA GA-3’
   PC5/6 5’-CAG AAG CCA TGG TGA TGG AG-3’ 5’-AGA GGG CGA GGT CAG GTA GA-3’
   PC7 5’-GCT TGT CAT CAG GGA TGT CG-3’ 5’-AAG GAG GTC AGA GGT GGT GG-3’
   PACE4 5’-TCA AGA CCA GCA GGA AGT GC-3’ 5’-CCT TCG ACA CAC TTT GTG GG-3’
   Furin 5’-CCA CAG ACC CCA AGT TTC CT-3’ 5’-GTG CCT CCA CTG CAT CTG TC-3’
   GATA-2 5’-CGC CTG TGG CCT CTA CTA CA-3’ 5’-CCA TCT GTT CCC TAG CCC AT-3’
   c-Myb 5’-CAC TGG GAA GGG GAC AGT CT-3’ 5’-GTC TCA CAT GAC CAG CGT CC-3’
   FOG-1 5’-CTG TGA AGA AGG AGC CAG CA-3’ 5’-GAC AGG CAG ATC AGG CAC AC
   RUNX1 5’-AGA AAT CAT TGA GTC CCC CG-3’ 5’-AGC ACG GAG CAG AGG AAG TT-3’
   LMO2 5’-ATC GAA AGG AAG AGC CTG GA-3’ 5’-CGG GCC TAT ATC ATC CCA TT-3’
   NF-E2 5’-CAA CTT ACT GCC CCT GCT CA-3’ 5’-CAA GGA GTT GGG CAT GAG TG-3’
   EKLF 5’-TGG CCT CTG AGA GTG AGT GC-3’ 5’-CGT CCG TGT GAA GAG ACC AC-3’
   NDRG2 (36) 5’-GGA TTC ATG GCG GAG CTG CAG GAG G-3’ 5’-GAA TTC TCA ACA GGA GAC CTC CAT GGT-3’
§Number indicates the reference.
Isolation of cytoplasmic and nuclear fraction
The cells were suspended with 100μl cold buffer A (25 mM 
Tris, pH 8.0, 10 mM KCl, 1 mM DTT, 0.5 mM PMSF) and 
incubated on ice for 15 min. Then, 25μl 10% NP-40 was add-
ed to the sample and mixed by vortexing for 10 sec. After 
centrifugation for 2 min at 4
oC, supernatants were collected 
as the cytoplasmic fraction. The pellet was suspended in 50μl 
buffer  C  (50  mM  Tris,  pH  8.0,  400  mM  NaCl,  1  mM  DTT, 
1 mM PMSF) and incubated for 10 min at 4
oC on a shaking 
platform. After centrifugation for 5 min at 4
oC, supernatants 
were  collected  as  the  nuclear  fraction.
Trypan blue exclusion assay
The cells were cultured in a 24-well plate in RPMI 1640 me-
d i u m  c o n t a i n i n g  1 0 %  F B S  a n d  t r e a t e d  w i t h  0 . 1μg/ml  PMA 
for 2 days. The cells were harvested every 1 day, stained with 
0.4% trypan blue, and live cells were counted using a hema-
tocytometer.
CCK-8 assay
The cells were seeded at a density of 1×10
4  cells/150μl in 
96-well plates in RPMI-1640 medium containing 10% FBS and 
treated with 0.1μg/ml PMA for 2 days. Then, 10μl of CCK-8 
solution  (Dojindo,  Gaithersburg,  MD)  was  added  to  each 
well. After incubation for 2∼3 h at 37
oC, the absorbance at 
4 5 0  n m  w a s  r e c o r d e d  u s i n g  a  V I C T O R 3
TM p l a t e  r e a d e r  
(PerkinElmer,  Waltham,  MA).NDRG2 Induces GATA-1 in PMA-stimulated U937 Cells
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Figure 1. Overexpression of NDRG2
in U937 cells. (A) Cell lysates were 
fractionated into cytoplasmic and 
nuclear components. Western blot-
ting using an anti-NDRG2 antibody 
was performed for each fraction. 
Lamin A/C and α-actinin were used
as control for protein loading as 
well as marker proteins for nuclear 
and cytoplasmic fraction, respecti-
vely. (B, C) U937-mock and U937- 
NDRG2 cells were treated with 0.1
μg/ml PMA for 48 h. Cell viability 
was determined using either the try-
pan blue exclusion assay (B) or the 
CCK-8 assay (C). The results repre-
sent the means±SD of duplicates. 
*p＜0.05, **p＜0.01. (D) PU.1, 
CSF-1R, and NDRG2 mRNA levels 
were measured by RT-PCR. β-actin 
was used as a loading control.
Statistical analysis
All the experiments were performed more than three times. 
The Student’s t-test was used for statistical analysis. The val-
ues  are  represented  as  the  mean±SD.  A  value  of  p＜0.05 
was  considered  significant.
RESULTS
NDRG2 overexpression prevents cell growth arrest in 
response to PMA
U937  cells  differentiate  into  monocyte-like  cells  upon  treat-
ment with phorbol 12-myristate 13-acetate (PMA), and their 
growth  is  arrested  by  enhanced  expression  of  PU.1-depen-
dent genes (22). To identify the effect of NDRG2 expression 
during PMA-induced differentiation in U937 cells, U937-mock 
and  U937-NDRG2  cells  were  treated  with  PMA  for  48  h. 
Ectopic expression of NDRG2 was detected only in the cyto-
plasm of U937 cells (Fig. 1A). After treatment with PMA for 
48  h,  U937-mock  cells  attached  to  culture  plate,  but  U937- 
NDRG2 cells showed comparatively reduced attachment (data 
not shown). A trypan blue exclusion assay revealed that both 
U937-mock and U937-NDRG2 cells showed no significant dif-
ferences in cell proliferation. However, U937-mock cells did 
not proliferate more in response to PMA. Interestingly, U937- 
NDRG2 cells continued to proliferate during PMA-induced dif-
ferentiation into macrophages (Fig. 1B). In addition, it was also 
confirmed using a CCK-8 assay that U937-NDRG2 cells main-
tained  a  higher  level  of  proliferation  than  U937-mock  cells 
during  PMA-induced  differentiation  (Fig.  1C).  Interestingly, 
NDRG2 expression significantly inhibited PU.1 expression in 
U937 cells although PU.1 levels were also weakly increased 
in  U937-NDRG2  cells  after  treatment  with  PMA  (Fig.  1D). 
Consistent  with  these  results,  CSF-1R  expression,  which  is 
regulated  by PU.1, was not observed in  U937-NDRG2 cells 
after  treatment  with  PMA.  Accordingly,  these  data  demon-
strate  that  NDRG2  hinders  the  differentiation  of  U937  pre- 
monocytes  into  macrophages  by  PMA  stimulation  and  pro-
motes continued cell growth through the suppression of PU.1 
expression.
GATA-1 expression is induced by NDRG2 overexpres-
sion
PU.1,  which  is  suppressed  by  NDRG2  expression  in  U937 
cells, has a reciprocal interaction with GATA-1 during hema-
topoiesis.  Thus,  we  examined  whether  NDRG2  induces 
GATA-1 expression in U937 cells. As shown in Fig. 2A and NDRG2 Induces GATA-1 in PMA-stimulated U937 Cells
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Figure 2. NDRG2 induces GATA-1 
expression. (A) U937-mock and 
U937-NDRG2 cells were treated 
with 0.1μg/ml PMA for 48 h. mRNA
levels for GATA-1 and NDRG2 were
measured by RT-PCR. β-actin was 
used as a loading control. (B) Equal 
amounts of whole protein lysates 
were subjected to electrophoresis 
on SDS-PAGE gels, and Western blot
analysis was performed using speci-
fic antibodies. Actin was used as an 
internal loading control. (C) Expres-
sion of genes promoting the differen-
tiation of erythrocyte and mega-
karyocyte. U937-mock and U937- 
NDRG2 cells were treated with 0.1
μg/ml PMA for 48 h prior to RT- 
PCR analysis.
B,  when  U937-mock  and  U937-NDRG2  cells  were  treated 
w i t h  P M A  f o r  4 8  h ,  G A T A - 1  e x p r e s s i o n  a t  b o t h  t h e  m R N A 
and  the  protein  levels  was  only  detected  in  PMA-treated 
U 9 3 7 - N D R G 2  c e l l s .  T h e s e  d a t a  s u g g e s t  t h a t  a l t h o u g h  P U . 1  
levels  in  U937-NDRG2  cells  are  weakly  induced  after  stim-
ulation  with  PMA,  GATA-1  expression  is  remarkably  en-
hanced  by  NDRG2  expression.
GATA-1 induction by NDRG2 correlates with the gene 
expression patterns marking differentiation into ery-
throcytes/megakaryocytes
Because GATA-1, which is increased by NDRG2 overexpres-
sion in response to PMA, is essential for differentiation of er-
ythrocytes and megakaryocytes, we explored whether NDRG2 
controls the expression levels of other genes that regulate er-
ythroid/megakaryocyte  differentiation  processes.  It  is  well 
known that a number of factors help to promote the differ-
entiation of erythrocytes and megakaryocytes, including FOG- 
1, NF-E2, RUNX1, SCL/tal, LMO2, EKLF, and c-Myb (23,24). 
U937-mock and U937-NDRG2 cells were treated with 0.1μg/ 
ml PMA and gene expression was analyzed after 48 h using 
RT-PCR. mRNA expression of NF-E2, RUNX1, LMO2, c-Myb, 
and  FOG-1  was  detected  in  both  U937-mock  and  U937- 
NDRG2  cells  in  the  absence  of  PMA  stimulation  (Fig.  2C). 
Interestingly, the expression of these factors was strongly in-
hibited by treatment with PMA in U937-mock cells but was 
maintained in U937-NDRG2 cells. Moreover, EKLF expression 
was newly induced in U937-NDRG2 cells. Additionally, GATA- 
2, which is often replaced by GATA-1 during hematopoiesis, 
disappeared in U937-NDRG2 cells. Collectively, these results 
indicate that NDRG2 can help to maintain the expression of 
other genes involved in promoting the differentiation of eryth-
rocytes  and  megakaryocytes.
JAK2/STAT signaling is activated by NDRG2 expres-
sion
To  better  define  the  mechanism  that  regulates  GATA-1  ex-
pression  by  NDRG2,  we  investigated  whether  NDRG2  can 
control  the  activation  of  the  JAK2/STAT  pathway,  which  is 
involved in GATA-1 expression. After a 48 h treatment with 
0.1μg/ml PMA, protein production and mRNA expression of 
related genes were analyzed in U937-mock and U937-NDRG2 
cells.  As  shown  in  Fig.  3A,  phosphorylation  of  JAK2  and 
STAT1  was  markedly  increased  by  NDRG2  expression  and 
PMA stimulation. The phosphorylation of STAT3 and STAT5 
was severely impaired by PMA treatment in U937-mock cells, 
whereas  phosphorylation  was  maintained  in  U937-NDRG2 
cells. SOCS family proteins serve as negative regulators of the NDRG2 Induces GATA-1 in PMA-stimulated U937 Cells
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Figure 3. JAK2/STAT pathway is activated by NDRG2 expression. U937-mock and U937-NDRG2 cells were treated with 0.1μg/ml PMA for 48
h. Western blot analysis (A, B) and RT-PCR (C) were performed. α-actinin and β-actin were used as an internal loading control.
Figure 4. BMP-4/Smad signaling pathway is activated by NDRG2 expression. U937-mock and U937-NDRG2 cells were treated with 0.1μg/ml
PMA for 48 h. (A) Equal amounts of whole cell lysates were subjected to electrophoresis on SDS-PAGE gels, and Western blot analysis was 
performed using specific antibodies. Actin was used as an internal loading control. (B, C) mRNA levels were measured by RT-PCR.
JAK/STAT  pathway.  U937-mock  c e l l s  s h o w e d  a n  i n c r e a s e d  
expression  of  SOCS3  after  treatment  with  PMA,  whereas 
U937-NDRG2 cells did not (Fig. 3B and C). Other SOCS fam-
i l y  p r o t e i n s  d i d  n o t  s h o w  a n y  s i g n i f i c a n t  a l t e r a t i o n s  b y  
NDRG2  expression.  Together,  our  findings  suggest  that 
NDRG2  activates  JAK2/STAT  signaling,  which  can  mediate 
GATA-1  expression  in  U937  cells  in  response  to  PMA.
BMP-4/Smad signaling is activated by NDRG2
To  evaluate  other  mechanisms  by  which  NDRG2-induced 
GATA-1 expression is regulated, we further examined wheth-
er NDRG2 can control the activation of the BMP-4/Smad path-
way that is associated with the induction of GATA-1 expres-
sion. After 48 h of treatment with 0.1μg/ml PMA, Western 
blot  analysis  was  performed.  NDRG2  expression  promoted 
the production of active BMP-4 (37 kDa) in PMA-treated U937 
cells (Fig. 4A). Consistent with BMP-4 production, phosphor-NDRG2 Induces GATA-1 in PMA-stimulated U937 Cells
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Figure 5. NDRG2 increases GATA-1 expression through regulation of JAK2/STAT pathway. U937-NDRG2 cells were pre-treated with 5μg/ml
AG490 (A), 1μM dorsomorphin (DM) (B), or 5 ng/ml noggin (C) for 3 h and then, 0.1μg/ml PMA was added. After 48 h, Western blot analysis
was performed.
ylation of Smad1/5/8, which can be induced by active BMP-4, 
was  also  detected  only  in  PMA-treated  U937-NDRG2  cells. 
These  results  demonstrate  that  NDRG2  can  activate  the 
BMP-4/Smad pathway when cells are stimulated with PMA.
NDRG2 regulates the expression of PC and BMPR to 
modulate the BMP-4/Smad signaling pathway
BMP-4,  similar  to  other  TGF-β family  members,  binds  to 
type I and type II serine/threonine kinase receptors. Type I 
receptors  are  activated  by  phosphorylated  type  II  receptors 
to initiate intracellular signals through the activation of Smad 
proteins  (25-27).  We  therefore  evaluated  the  effects  of 
NDRG2 on BMP receptor (BMPR) expression in response to 
PMA. Type I receptors include BMPRIA, BMPRIB, and ActRI. 
Type II receptors include BMPRII, ActRII, ActRIIB. As shown 
in  Fig.  4B,  BMPRIA  expression  was  inhibited  by  treatment 
with PMA in U937-mock cells but increased in U937-NDRG2 
cells. The expression of ActRI and ActRII was enhanced by 
NDRG2  expression.  Although  the  expression  of  ActRI  and 
ActRII was detected in U937-mock cells in response to PMA, 
it  was  still  higher  in  U937-NDRG2  cells.  Expression  of 
BMPRIB, BMPRII, and ActRIIB was highly induced in PMA- 
treated U937-NDRG2 cells. These data show that NDRG2 ex-
pression generally increases expression of BMPR in U937 cells 
and also suggest that phosphorylation of Smad1/5/8 may be 
induced  by  the  increased  BMPR  activation  in  PMA-treated 
U937-NDRG2  cells.
    The  activity  of  BMP-4  is  regulated  by  pro-protein  con-
vertase (PC) family members. Nine members of the PC fam-
ily,  including  PC1/3,  PC2,  PC4,  PC5/6,  PC7,  PACE4,  Furin, 
SKI-1/S1P, and PCSK9, have been identified (28). The seven 
PCs, except for SKI-1/S1P and PCSK9, cleave pro-proteins at 
single or pairs of basic residues in the Golgi, secretory gran-
ules, cell surface, or endosomes. In particular, PC5/6, PC7, 
PACE4, and  Furin are known to cleave pro-BMP-4 (29-31). 
As shown in Fig. 4C, expression of PC2, PC4, and PC5/6 in-
creased with NDRG2 expression. Although the expression of 
PC2 and PC4 was detected in U937-mock cells in response 
to  PMA,  their  expression  was s t i l l  h i g h e r  i n  U 9 3 7 - N D R G 2  
cells. Furin was expressed only in PMA-treated U937-NDRG2 
cells.  These  data  suggest  that  NDRG2  expression  increases 
the expression of PC to promote production of active BMP-4.
NDRG2 modulates GATA-1 expression through regu-
lation of the JAK2/STAT pathway but not through re-
gulation of the BMP-4/Smad pathway
To identify which pathway regulates NDRG2-mediated GATA- 
1 expression, U937-NDRG2 cells were pre-treated with a JAK2 
inhibitor (AG490), a BMP-4 antagonist (Noggin), or a Smad1/ 
5/8  inhibitor  (dorsomorphin).  As  shown  in  Fig.  5A,  phos-
phorylation of JAK2 was suppressed by AG490 treatment in 
U937-NDRG2  cells.  Phosphorylation  of  Smad1/5/8  was  not 
significantly altered by JAK2 inhibition in U937-NDRG2 cells. 
Importantly, PMA-induced GATA-1 expression was inhibited 
by pre-treatment with AG490 in U937-NDRG2 cells. PMA-in-
duced Smad1/5/8 phosphorylation was decreased by pre-treat-
ment  with  dorsomorphin  (DM) or  noggin (Fig. 5B and C). 
Phosphorylation of JAK2 was not regulated by treatment with 
dorsomorphin or noggin. Interestingly, PMA-induced GATA-1 
expression  was  not  inhibited  by  pre-treatment  with  DM  or NDRG2 Induces GATA-1 in PMA-stimulated U937 Cells
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noggin  in  U937-NDRG2  cells.  Together,  these  data  suggest 
that NDRG2 increases GATA-1 expression through the regu-
lation of the JAK2/STAT pathway, but not through regulation 
of  the  BMP-4/Smad1/5/8  pathway,  in  response  to  PMA.
DISCUSSION
NDRG2  belongs  to  the  NDRG  family,  a  new  characterized 
group of differentiation-related genes composed of four fam-
ily members (13). NDRG2 has been characterized as a regu-
lator of dendritic cell differentiation from monocytes, CD34
＋ 
progenitor  cells,  and  myelomonocytic  leukemic  cell  line 
(14,15). Recently, it was suggested to be a novel intrinsic fac-
tor for the modulation of IL-10 production in myeloid cells 
(20). However, the role of NDRG2 in the expression and acti-
vation of transcription factors in hematopoietic cells remains 
poorly  understood.
    Since Friend et al.(32) first demonstrated an induction of 
murine  virus-induced  erythroleukemic  cell  (MEL)  differ-
entiation in vitro in the early 1970s, several groups have used 
malignant  hematopoietic  cell  lines,  including  HL-60,  K-562, 
HEL,  U937,  TF-1,  ML-1,  and  KG-1,  to  study  hematopoiesis. 
We used U937 myeloid leukemic cells to investigate the effect 
of NDRG2 on GATA-1 expression. Myeloid leukemic cells dif-
ferentiate in response to PMA, and their growth is arrested 
by  increased  expression  of  PU.1-dependent  genes  (22).  In 
our  study,  PMA-treated  U937  cells  showed  suppression  of 
proliferation  or  differentiation  into  monocyte-like  cells, 
whereas  U937-NDRG2  cells  continued  their  growth  in  re-
sponse to PMA (Fig. 1B and C). In addition, NDRG2 impaired 
PU.1  expression  in  U937  cells  (Fig.  1D).
  In a previous report, it was shown that NDRG2 activates 
the  STAT3  pathway  in  PMA-treated  U937  cells  (21).  More
over,  NDRG2  induced  BMP-4  production  in  MDA-MB-231 
breast  cancer  cells  (17).  Because  STAT3  and  BMP-4  are 
known  regulators  of  GATA-1  expression,  and  PU.1  sup-
pression by NDRG2 is regulated by GATA-1 in an antagonistic 
manner, we hypothesized that NDRG2 increases GATA-1 ex-
pression  through  the  regulation  of  the  JAK2/STAT  or 
BMP-4/Smad signaling pathway. While U937-mock cells did 
not express GATA-1, U937-NDRG2 cells showed an increased 
GATA-1 expression in response to PMA after 48 h (Fig. 2). 
NDRG2  did  not  appear  to  form  a  complex  with  GATA-1, 
which  was  induced  by  NDRG2  overexpression  in  response 
to  PMA  (data  not  shown).  It  has  previously  been  reported 
that NDRG2 is downregulated by myc (13). GATA-1 is able 
t o  p r o m o t e  r e p r e s s i o n  o f  t h e  c - m y c  p r o t o - o n c o g e n e  d u r i n g 
erythroid maturation (33). Thus, it is conceivable that a pos-
itive  feedback  loop  exists  between  GATA-1  and  NDRG2.
    There are many proteins capable of controlling the differ-
entiation of erythroid and megakaryocytic cells. Most of these 
genes, including NF-E2, RUNX1, LMO2, c-Myb, and FOG-1, 
were expressed in both U937-mock and U937-NDRG2 cells. 
H o w e v e r ,  t h e i r  e x p r e s s i o n  w a s  i nhibited  by  treatment  with 
PMA  in  U937-mock  cells  but  maintained  in  U937-NDRG2 
cells. Moreover, the EKLF gene, which is specific for eryth-
roid lineages, was only expressed in U937-NDRG2 cells, and 
RUNX1,  which  is  specific  for  megakaryocyte  lineages,  was 
stably  expressed  even  after  treatment  with  PMA.  Because 
both EKLF and RUNX1 were modulated by NDRG2 in U937 
cells, the type of lineage specifically regulated by NDRG2 still 
remains  unclear.  GATA-2,  which  promotes  proliferation  of 
progenitor cells during early hematopoiesis and is suppressed 
by GATA-1 directly during hematopoiesis (34), was detected 
i n  U 9 3 7 - m o c k  c e l l s  b u t  n o t  i n  U 9 3 7 - N D R G 2  c e l l s  ( F i g .  3 ) .  
Based on these results, we speculate that NDRG2 expression 
can regulate the expression of other genes that promote the 
differentiation  of  erythrocytes  and  megakaryocytes.  There-
fore, further studies of how NDRG2 controls gene expression 
involved  in  hematopoiesis  dependent  or  independent  of 
GATA-1  are  warranted.
    It has been suggested that various genes are involved in 
GATA-1  expression  during  embryonic  developmental  proc-
esses  and  hematopoiesis.  We  previously  reported  that 
NDRG2 expression activates the STAT3 pathway upon treat-
ment  with  PMA  for  up  to  60  min  in  U937  cells  (21). 
F u r t h e r m o r e ,  N D R G 2  i n c r e a s e d  B M P - 4  p r o d u c t i o n  i n  M D A -  
MB-231 breast tumor cells (17). Thus, we hypothesized that 
NDRG2 induced GATA-1 expression through regulation of the 
JAK2/STAT  or  BMP-4/Smad  pathway.  As  shown  in  Fig.  3, 
NDRG2 promoted or maintained the phosphorylation of the 
JAK2/STAT  pathway,  whereas  NDRG2  expression  inhibited 
t h e  e x p r e s s i o n  o f  S O C S 3 ,  a  n e g a t i v e  r e g u l a t o r  o f  t h e  J A K /  
STAT pathway, in response to PMA for 48 h in U937 cells. 
Moreover, NDRG2 expression induced protein expression of 
active  BMP-4  and  activated  Smad1/5/8  in  response  to  PMA 
for 48 h in U937 cells (Fig. 4A). BMP-4 binds to type I and 
type II serine/threonine kinase receptors and activates intra-
cellular signals through the phosphorylation of Smad proteins 
(25-27). As shown in Fig. 4B, expression of various BMP re-
ceptors  was  enhanced  by  NDRG2  when  cells  were  treated 
with PMA. Furthermore, the expression of PCs, which regu-NDRG2 Induces GATA-1 in PMA-stimulated U937 Cells
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late  cleavage  of  pro-BMP-4  to  active  BMP-4,  increased  due 
to NDRG2 expression (Fig. 4C). Together, these findings sug-
gest that NDRG2 expression can induce PC expression, pro-
duce  active  BMP-4,  and  phosphorylates  Smad1/5/8  through 
increased  BMPR  activity  in  U937  cells.
    To  identify  the  signal  transduction  pathways  by  which 
NDRG2 induces GATA-1 expression, we analyzed JAK-STAT 
and BMP4-SMAD pathways using specific inhibitors. PMA-in-
duced GATA-1 expression was suppressed by pre-treatment 
with AG490, a JAK2 inhibitor, in U937-NDRG2 cells (Fig. 5A). 
However,  dorsomorphin  (DM),  a  Smad1/5/8  inhibitor,  and 
noggin, a BMP-4 antagonist, did not have any inhibitory effect 
on  PMA-induced  GATA-1  expression  in  U937-NDRG2  cells 
(Fig. 5B and C). Recently, the cross-talk  between the BMP 
and  JAK/STAT  signaling  pathways  has  been  a  focus  of  re-
search to better understand hematopoiesis, embryonic devel-
opment, and leukemia development (5). When the relation-
ship between the BMP-4/Smad and JAK/STAT pathways was 
evaluated using specific inhibitors in PMA-treated U937-NDRG2 
cells,  there  was  no  significant  effect  on  activation  of  either 
pathway (Fig. 5), raising the possibility that these systems act 
independently.
  In summary, we report in this study that NDRG2 induces 
GATA-1 expression through activation of the JAK2/STAT sig-
naling  pathway,  but  not  through  BMP-4/Smad  signaling,  in 
PMA-treated  U937  cells.  These  results  suggest  that  NDRG2 
may serve as a regulator in erythrocyte and megakaryocyte 
differentiation during hematopoiesis. Further study is required 
t o  i d e n t i f y  t h e  e f f e c t s  o f  N D R G 2  e x p r e s s i o n  o n  t h e  d i f f e r -
entiation  of  erythroid/megakaryocytic  lineages  in  primary 
hematopoietic stem cells and in vivo. Moreover, study of the 
effects of NDRG2 expression on myeloid cell differentiation 
through the activation of the BMP-4/Smad pathway also re-
quires  further  elucidation.
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